Evaluating Development and Production Costs: Tablets versus Capsules

Research illustrating that capital outlay for developing and producing NCEs in capsules, over tablets, is reduced and results in shorter time to market by Graham Cole, a pharmaceuitcal process engineer based in the U.K.

Download White Paper